Clinical trial
Dipyridamole/Magnesium To Improve Sickle Cell Hydration
NCT00276146 · Children's Hospital Medical Center, Cincinnati, Other · Withdrawn
Key facts
| NCT number | NCT00276146 |
|---|---|
| Title | Dipyridamole/Magnesium To Improve Sickle Cell Hydration |
| Official title | Dipyridamole/Magnesium To Improve Sickle Cell Hydration |
| Lead sponsor | Children's Hospital Medical Center, Cincinnati, Other |
| Status | Withdrawn |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Anemia, Sickle Cell |
| Intervention type | Drug |
| Interventions | oral dipyridamole, oral magnesium, or a combination of both |
| Enrollment | 0 |
| Start date | May 1, 2005 |
| First posted | Jan 13, 2006 |
| Last update posted | Aug 7, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: